The Informatised Follow Up of the Therapeutics Effects of Levonorgestrel Releasing Intrauterine Device - Mirena^®

Abstract

The levonorgestrel intrauterine system (LNGIUS) offers a new therapeutic concept that combines a highly efficient contraceptive effect. The device is also used in the therapy of idiopathic menorrhagia. Our study analyses the therapeutically efficiency of an intrauterine medical device (Mirena) used by patients with idiopathic menorrhagia for one year. 20 woman patients were supervised based on a trimestrial questionnaire, sent by the patient to their gynecologist. At the beginning and at end of the study all the patients have submitted a clinical and ultrasound evaluation. Also usual hematological examinations have been performed. The results showed a significant decrease in duration and quantity of menstrual bleeding (p<0.05). The correlation between the electronic data and clinical data was very good (p<0.05), and the acceptance of monitoring system used was excellent. We can conclude that the Mirena treatment is efficient, well tolerated and is suitable for internet medical follow-up.